Bristol-Myers Squibb Company

BMY
Healthcare
$58.80
4.29%Fair Value

Bristol-Myers Squibb Company (BMY) is a Healthcare company that currently yields 4.29% — trading near fair value based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $48.42 and the overvaluation threshold at $74.62. Bristol-Myers Squibb Company holds a quality score of 30/100 (Risky), reflecting 4 consecutive years of dividend growth with a 56% payout ratio. The 5-year dividend CAGR stands at 1.6%.

BMY Dividend Yield History — Weiss Valuation

Underval. $48.42Overval. $74.62

Distance to undervalued

Waiting for a better entry

Needs about 17.6% downside to reach the Weiss buy zone

Undervaluation starts near $48.42, where the annual dividend would imply roughly 5.20% yield. That is 0.92% above today's yield.

Buy-zone price

$48.42

Target yield

5.20%

Research checklist

What to clear before buying the yield

Updated Nov 21, 2026

Dividend durability

4Y

Verify the dividend record before treating yield as durable.

Earnings payout

56%

Earnings coverage leaves room for noise.

Cash payout

81%

Free cash flow coverage supports the payment.

Dividend growth

1.6%

Lower growth changes the return trade-off.

What changed

What changed since the last update

2026-11-20 → 2026-11-21

Price

-1.2%

$59.49 → $58.80

Price fell 1.2% since the prior snapshot.

Why Now?

Bristol-Myers Squibb Company is trading at a fair valuation relative to its dividend history.

Current yield 4.3% vs historical max 6.1% (70% of maximum).

4 years of uninterrupted dividends.

Conservative payout ratio of 56%.

What matters now

Read the signal before the headline yield

Valuation is neutral here: quality has to do more of the work than entry price.

The 30/100 quality score says the headline yield needs extra skepticism.

Start by checking whether payout coverage and business durability still support the dividend.

BMY Dividend Income Projection — DRIP Compounder

Dividend Compounder (DRIP)

$

Year 1 Income

$435

Year 10 Income

$756

Yield on Cost

7.94%

Total Income

$5,801

Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.

Track actual vs. projected

See what BMY dividends you actually received with Sharesight

Dividend income log · Yield on cost · DRIP cost basis · Tax reports

→

More research

Full price history & technical analysis

TradingView ↗

Fundamentals, valuation & analyst ratings

FinViz ↗

Moat rating & analyst fair value

Morningstar ↗

Track dividends received & tax reports

Sharesight ↗

BMY Dividend Quality Score

Quality Score

30/ 100

Risky

Payout Ratio12/25
Dividend Streak5/25
Growth (CAGR 5Y)3/20
Yield vs History5/15
FCF Coverage5/15

Key Metrics

Current Price$58.80
Annual Dividend$2.52
Current Yield4.29%
Yield — Max (10Y)6.14%
Yield — Min (10Y)3.27%
Undervalued Below$48.42
Overvalued Above$74.62
Payout Ratio55.88%
CAGR Dividend 5Y1.6%
CAGR Dividend 10Y5.2%
Years No Cut4y

Invest in BMY

Check Bristol-Myers Squibb Company availability and current costs on eToro

Check eToro terms and availability →
Fractional sharesFees vary by countryCapital at risk

DividendVisual may earn a commission if you open an account via this link, at no cost to you. Capital at risk. Not financial advice.

4
consecutive years of dividend growth